LINEZOLID, 600mg, breakable tab., blister

STD DORALINE6TB1

Valid Article

6.2.3 - Reserve group antibiotics
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
6.2.5 - Antituberculosis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J01XX08
Anatomical Therapeutic Chemical Classification according to WHOCC
The order of this product needs to be justified and is only acceptable under certain conditions.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   

Add Kit To Wishlist

   

LINEZOLID

Therapeutic Action

Oxazolidinone bactericidal

Indications

Drug-Resistant Tuberculosis (DR-TB), in combination with other TB medicines

Some restricted information has been hidden. Sign in to see this information

Instructions for use

The dispersible tablet is intended for paediatric use.

The 600 mg breakable tablet should replace the normal 600 mg tablet.

Blister packaging is the packaging of choice for antituberculosis medicines due to the unstable nature of some of them when exposed to higher temperatures and humidity.

The quantity to be ordered is calculated per tablet, not per blister.

It is recommended to administer pyridoxine (Vit B6) PO to all patients to prevent linezolid-associated myelosuppression.

Storage

Below 25ºC - Protect from sunlight - Protect from humidity